| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Teriparatide | FAERS: 17 | US FAERS | |
| 2 | Naltrexone | FAERS: 7 | US FAERS | |
| 3 | Zoledronic Acid | FAERS: 5 | US FAERS | |
| 4 | Lenalidomide | FAERS: 3 | US FAERS | |
| 5 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 6 | Everolimus | FAERS: 2 | US FAERS | |
| 7 | Risedronic Acid | FAERS: 2 | US FAERS | |
| 8 | carbidopa, levodopa drug combination | FAERS: 2 | US FAERS | |
| 9 | Alendronate | FAERS: 1 | US FAERS | |
| 10 | Alprazolam | FAERS: 1 | US FAERS | |
| 11 | Bortezomib | FAERS: 1 | US FAERS | |
| 12 | Capecitabine | FAERS: 1 | US FAERS | |
| 13 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 14 | Fluticasone propionate mixture with Salmeterol xinafoate | FAERS: 1 | US FAERS | |
| 15 | Ibandronic Acid | FAERS: 1 | US FAERS | |
| 16 | Octreotide | FAERS: 1 | US FAERS | |
| 17 | Pregabalin | FAERS: 1 | US FAERS | |
| 18 | Viekira Pak | FAERS: 1 | US FAERS | |
| 19 | acetaminophen, aspirin, caffeine drug combination | FAERS: 1 | US FAERS | |
| 20 | ambrisentan | FAERS: 1 | US FAERS | |
| 21 | apremilast | FAERS: 1 | US FAERS | |
| 22 | idelalisib | FAERS: 1 | US FAERS | |
| 23 | indacaterol | FAERS: 1 | US FAERS | |
| 24 | regadenoson | FAERS: 1 | US FAERS | |
| 25 | regorafenib | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.